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CHAPTER I 
 
 
INTRODUCTION 
Heart valve diseases claim more than 250,000 victims each year in the United 
States. One treatment is to replace the diseased heart valves with prosthetic heart valves 
(PHVs). PHVs have a long history of saving people’s lives - about 4 million PHV 
replacements have been placed into patients over the past 50 years. There are two 
commonly used PHVs, mechanical heart valves (MHVs) and bioprosthetic heart valves 
(BHVs). The advantage of BHVs is that patients do not need anticoagulant treatment, but 
the morphological changes and the structure failures have limited their viability. MHVs 
have stronger mechanical properties than BHVs, so they have longer durability which can 
lower the chance of second valve surgery. However, the changes of hemodynamics 
following the placement of MHVs can increase the risk of thromboembolism and other 
cardiac complications, which can lead to mortality. Patients with MHV are required to 
have anticoagulant treatment for the rest of their life. These insufficiencies of current 
PHVs have led to the development of new PHVs, either better in designs or using better 
materials. Polymer heart valves have attracted scientists’ attention as a viable alternative 
to MHVs or BHVs. This is not a completely new idea and it has been under investigation 
for nearly 50 years. However, none of the proposed polymeric heart valves are suitable 
for patient use yet. An ideal polymer heart valve should be a good combination of MHV  
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and BHV, which should not suffer from morphological changes, have good durability and 
should not cause thrombogenicity. 
To evaluate the dynamic performance of PHVs, numerical simulation (e.g., 
computational fluid dynamics, or CFD), in vitro experiments and in vivo experiments can 
all be used.  CFD can give a good estimation of flow dynamics induced by the heart 
valves, as long as the model is constructed with realistic geometry and flow conditions. In 
vitro experiments usually require a flow chamber to hold the heart valves, which can 
mimic the hemodynamic performance of the heart. The most commonly used flow 
chamber for this purpose is a left ventricular assist device (LVAD). However, the cost of 
LVAD is relatively high. In vivo experiments are more complicated than in vitro 
experiment because it requires heart valve implant into living animals’ heart. Usually, 
these animals have similar heart structure or size compared to the human heart.  In vivo 
experiment provides a better way to study the overall effects on a living object. In this 
study, we designed and manufactured a flow chamber, following the design of a LVAD, 
and use it to evaluate novel polymeric heart valves. Numerical simulation and in vitro 
experiments would be conducted to evaluate the suitability of this flow chamber to 
perform heart valve studies. 
Hemodynamics and flow pattern changes induced by the implantation of PHVs 
can increase mechanical stress and lead to blood damage. Platelets and red blood cells are 
sensitive to altered mechanical stresses. Shear stress is the major mechanical stress that 
can cause platelet activation. Elevated shear stress can lead to platelet activation and 
thromboembolism. Abnormal shear stress can break red blood cells membrane elasticity 
and cause membrane damage. Hemoglobin in the red blood cells will be released into 
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surrounding fluid which will lead to the reduction of oxygen transportation by blood to 
other tissues in the body.   
The major goal of this thesis was to design and fabricate a flow chamber 
suitable for heart valve studies. We would test its biocompatibility towards blood 
under static and dynamic conditions.  
  The specific aims of this study are listed as the following. 
Specific Aim 1: To design and fabricate a flow chamber following the concept of a left   
ventricular assist device to study the performance of prosthetic heart 
valves.   
Specific Aim 2: To investigate the biocompatibility of the flow chamber to platelets and 
red blood cells in vitro.  
Specific Aim 3: To perform numerical simulation to study the flow dynamics in the flow 
system. 
  The flow chamber designed and fabricated through this study can be used in the 
future to evaluate hemodynamic performance of various PHVs. Knowledge obtained 
from this study would help us to design better PHVs (i.e., a polymeric heart valve) and 
benefit more patients in a long run.  
CHAPTER II 
 
 
BACKGROUND 
2.1 Anatomy of the heart 
 Human heart contains four chambers and the function of the heart is to pump 
blood to the whole body. Two upper chambers are the right atrium and the left atrium. 
The right atrium, receives blood from vena cava (systemic circulation) and the left atrium 
receives blood from pulmonary veins (pulmonary circulation). Two lower chambers are 
the right ventricle and the left ventricle. The right ventricle collects blood from the right 
atrium and pumps blood to pulmonary circulation. While the left ventricle collects blood 
from left atrium and pumps blood to systemic circulation. The left ventricular pressure is 
higher than that of the right ventricle because the left heart supplies blood to everywhere 
in the body. As a result, the left ventricle is much larger and has a thicker wall than the 
right ventricle.  The heart also has four unidirectional valves that prevent the backflow of 
blood when the chambers contract. The atrioventricular valves, between the ventricles 
and the atria, prevent the backflow of blood from the ventricles to atria during the 
contraction of ventricles. The pulmonary valve prevents the backflow from the 
pulmonary trunk to the right ventricle, while the aortic valve prevents backflow from 
aorta to the left ventricles (Frederic H.Martini and Judi L.Nath, 2009). Figure 2.1 shows 
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the layout of the chambers and the valves of the heart as well as blood flowing direction 
in and out of the heart. 
 
Figure 2.1: A model of transverse section of human heart which shows the location of 
different valves and blood flow direction (Frederic H.Martini and Judi L.Nath, 2009).  
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The cardiac cycle has two phases: diastole and systole. Diastole is part of the 
cardiac muscle relaxing, while systole is part of the cardiac muscle contracting during the 
cardiac cycle. The cardiac cycle usually takes about 800 msec and begins with atrial 
systole. When the atrial systole begins, about 70 percent of the normal ventricle 
capacities are already occupied by blood. As the atria contract, the pressure in the atrial 
increases and pushes the blood through AV valves to fill the remaining 30 percent. Each 
ventricle contains the maximum amount of blood at the end of atrial systole (end of 
ventricular diastole) and this amount is called the end-diastolic volume (EDV). The EDV 
for an adult standing at rest is about 130ml. Ventricular systole begins right after atrial 
systole ends. During this period, ventricular pressure keeps rising, until it is high enough 
to push open the valves (aortic valve and pulmonary valve), driving blood flow into the 
pulmonary and the aortic trunk. This is the beginning of ventricular ejection. When 
ventricular ejection starts, the left ventricle will eject 70 to 80ml of blood and this is 
known as stroke volume (SV) of the heart. During the end of ventricular systole, the 
pressure in the ventricular drops quickly. The amount of blood left in the ventricle when 
the pulmonary and aortic valve close is the end systolic volume (ESV). The ESV at rest is 
about 50ml and carries 40 percent of EDV (Frederic H.Martini and Judi L.Nath, 2009).     
The relationship between the ventricular pressure and volume can be presented in 
Wiggers diagram (Krisnan B.Chandran et al., 2007a). Wiggers diagram is a standard 
diagram that used in cardiac physiology. It interprets the relationship of the volume 
changes in the ventricular chamber with the atrial and ventricular pressure. Wiggers 
diagram can be used as a standard research that is related to human heart. Figure 2.2 
shows the Wiggers diagram in one cardiac cycle.  
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Figure 2.2: The Wiggers Diagram demonstrated the relationship between the pressure and 
volume changes in one cardiac cycle (Krisnan B.Chandran et al., 2007a). 
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2.2. Prosthetic heart valves 
 Heart valve disease is one of the major complications of the cardiovascular 
system and can lead to heart muscle disease. It can be caused by rheumatic fever, 
ischemic heart disease, bacterial or fungal infection, connective tissue disorders, trauma, 
and malignant carcinoid (Krisnan B.Chandran et al., 2007b). Any valve that causes the 
heart to unable to maintain normal circulatory flow is considered a diseased heart valve 
and the patient is called to have valvular disease (VHD). VHD always falls into two 
categories: stenosis and incompetence. The stenotic heart valve prevents the valve from 
opening fully due to the stiffened valve tissue. As a result, more work is required to push 
blood through the valve. On the other hand, the incompetent valve causes inefficient 
blood circulation and causes a backflow of blood into the heart. Both these conditions 
reduce the efficiency of the heart and increase stresses and strains on it. PHVs are 
commonly used today for replacing degenerated heart valves. About 4 million PHVs 
were used in patients over the past 50 years, and sometimes a heart valve replacement 
surgery is the only option for VHD patients. It is believed that the total number of 
replacement will increase to 850,000 per year by 2050 due to the higher rate of 
population increase (Yacoub and Takkenberg, 2005).  
PHVs can be either mechanical, polymeric or bioprosthetic. Among all the PHVs 
used, about 55% of them are mechanical ones and the remaining 45% are biological 
(Butany et al., 2003).  
 Mechanical heart valves (MHV) have been in use since 1950s. The very first 
MHV implanted into a human patient was a Hufnagel Valve, placed in the descending 
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thoracic aorta in 1952 (Hufnagel et al., 1954). The disadvantage of this design is that it 
can only be placed in the descending thoracic aorta instead of the heart itself, so it did not 
really solve the problem. However, it was a great achievement because it showed that 
PHVs could be used to treat VHD. Based on the design of the Hufnagel Valve, Starr-
Edwards caged ball valve was successfully implanted in 1960. The ball was trapped in a 
strut cage at both ends but could move freely (Figure 2.3A). The idea for the design was 
to reduce thrombus formation around the sewing ring (Grunkemeier et al., 2000). 
However, the ball blocked the center flow of blood and generated a wake of stagnant 
blood flow which led to a higher rate in thromboembolism (Yoganathan et al., 2004). In 
contrast, monoleaflet tilting valves and bileaflet valves can offer more physiological flow 
compared to Starr-Edwards caged ball valves. Single leaflet or tilting disk valves were 
introduced in later 1960s. These valves have a significant improvement compared to 
caged ball valves. They can provide more central flow of blood and reduce the risk of 
thromboembolism. Bjrok-Shiley was the first successful tilting-disk valve and was 
introduced to the world in 1969 (Bjork, 1969). The valve consisted of a single leaflet at 
the center which was held by a strut (Figure 2.3B). It provided good center flow and can 
prevent blood regurgitation. Unfortunately, strut fracture and thromboembolism were the 
main problems of the valve. Because of these problems, the production of the flat disc 
and convexo-concave disc Bjrok-Shiley valves was stopped in 1986 (Butany et al., 2003). 
St. Jude bileaflet MHV is the most commonly used MHV nowadays, which was 
introduced to the world in 1977. It was the first bileaflet valve that was made of pyrolitic 
carbon coated with graphite (Sun et al., 2009). It consists of two leaflets which can move 
around butterfly hinges (Figure 2.3C). This design provides the valve leaflets more 
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freedom in movement and helps to reduce the inertia for valve opening and closing. The 
advantages of bileaflet valves include that 1) the flow through the valve opening is 
symmetric, 2) there is little turbulence and more central flow compared to previous 
valves (Butany et al., 2003). However, patients with this type of valves still need lifelong 
anticoagulant treatment. 
 
Figure 2.3: Different models of PHVs. (A) Starr-Edwards caged ball valve. (B) Bjork-
Shiley tilting-disk valve. (C) St. Jude bileaflet valve. (D) Medtronic HK II ultra porcine 
valve. (E) Carpentier-Edwards Perimount bovine pericardial valve. (F) Edwards SAPIEN 
transcatheter pericardial aortic valve (Sun et al., 2009). 
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Bioprosthetic heart valves (BHV) were the solution to the thromboembolism 
problem faced by MHVs. BHVs are valves that are taken from animals. After certain 
chemical processes, they are suitable to be placed into human patients.  Porcine valves 
are the most widely used BHV in the market because their structure is the closest to a 
human valve (Figure 2.3 D). Potential risks associated with BHV implantation include 
calcification and possible immune responses.  Compared to MHVs, BHVs provide better 
hemodynamics since they are natural valve and can provide a better central flow. Patients 
with BHVs do not need anticoagulant treatments. Hancock valve is the first porcine valve 
that was manufactured commercially in 1970. It solved the hemodynamics problems that 
MHVs cannot solve in many years. However, morphological failure has limited the 
success of the valve.  Research has shown that tissue calcification was the main reason 
for the valve failure (Bortolotti et al., 1988). Calcification makes leaflet cusp stiff, 
resulting in stenosis and valve failure. It was also suggested that that porcine BHVs 
should be removed until a better bioprosthetic with better durability appear. Carpentier-
Ewards Perimount valve has improved the design by minimizing leaflet cusp stress and 
durability (Figure 2.3E). However, studies have shown that the valve was a good BHV 
for mitral valve replacement but only for patients older than 60 years old of age 
(Marchand et al., 2001). As a result, it limited the implantation for patients of certain age. 
Stentless bioprosthetic valves are different from stented bioprosthetic valves (Figure 
2.3F). Stentless valves have no frame on the structure, which can increase orifice area 
and provide better central flow. But a meta-analysis study has found that  patients with 
stentless valve would have larger left ventricular mass regression compared to the 
patients with stented valve (Kunadian et al., 2007).               
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  Due to the limitations in MHVs and BHVs, people have turned their attention to 
polymeric heart valves.  Researchers have hoped that with our advanced knowledge in 
new synthetic biomaterials and hemodynamics, we may be able to achieve a polymeric 
heart valve with better hemodynamic performances and mechanical properties. However, 
the early design of polymeric heart valves was not very successful because of the 
degradation of the materials. Polymeric heart valves are usually designed to mimic the 
natural heart valve structure so they generally have suitable hemodynamic properties. 
Material is a critical factor for the success of a polymeric heart valve, in terms of 
biocompatibility and durability. In theory, synthetic polymeric heart valves have the 
potential to overcome the problem faced by MHVs and BHVs. However, low 
biostability, poor hemocompatibility,  potential thrombogenicity and durability (Daebritz 
et al., 2004) are the major concerns that prevent polymeric heart valves from becoming 
an alternative option in heart valve replacement surgeries. If these problems can be 
solved, polymeric heart valves can serve as a good alternative to MHVs and BHVs.  
2.3 Left ventricular assist device 
Since the early 19th century, researchers have sought after a mechanical device 
that can mimic the activities of human heart to help or replace the heart with problems. 
However, it was only in 1950s that people started to use the mechanical devices to help 
patients with heart problems. In 1960s, the first ventricular assist device (VAD) was used 
on a human patient (Frazier, 2010). The initial function of VAD was to serve as a bridge 
to transplant, which means that it can help the patient survive until the donor heart 
becomes available. Nowadays, the number of patients with heart failure problems is 
increasing year by year and the heart donors are not sufficient to fulfill the patients’ need 
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for a heart transplant. Mechanical circulatory support through a VAD has become an 
option to the patients who do not have a candidate for heart transplant. VAD also can be 
used as a destination therapy and provide long term support for the patients. However, the 
cost of a left VAD for destination therapy is a high burden for patients. According to 
REMATCH, the average cost for VAD destination therapy from surgery to hospital 
discharge was about $210,187 (Oz et al., 2003). 
 A VAD is usually connected between the heart and a major artery. It helps the 
patient’s heart to pump blood throughout the whole body, by decreasing the workload of 
the heart. VADs are good mechanical circulatory devices. They provide a good flow 
environment for blood and are made with biocompatible materials.  
 VADs can also be used to study the in vitro performance of PHVs since they can 
provide a similar flow environment as what a normal heart can generate. However, the 
cost for the left VAD itself has prevented researchers from using them widely in their 
research laboratories. VADs that have a diaphragm are fairly commonly used. They 
generally consist of two fluid chambers separated by a flexible diaphragm. One of the 
fluid chambers contains blood and connects to the body with one inlet and one outlet. 
While another fluid chamber is filled with water or other fluid and connected to a pump. 
When the pump starts moving, it can generate pulsatile pressure upon the diaphragm. As 
the diaphragm deforms towards blood chamber, it pushes the blood to circulate. If a flow 
chamber with similar properties can be constructed, it will be ideal for researchers to 
conduct PHV studies at a low cost.   
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2.4 Computational fluid dynamics (CFD) 
CFD uses numerical methods and computational calculations to analyze complex 
fluid problems. It can provide detailed, two or three dimensional, and time varying 
information on flow conditions in complex geometries. In recent years, CFD has been 
widely used to investigate the hemodynamic performance of PHVs. Using CFD, the flow 
pattern changes induced by the implantation of a PHV can be estimated. For most of the 
studies of this type, the major focus is usually placed on the flow downstream of the 
valve, turbulence formation, shear stress produced and velocity field.  
Simon et al studied the three-dimensional hinge flow fields of a bileaflet 
mechanical heart valve under aortic conditions (Simon et al., 2010). They conducted the 
simulation by using Cartesian sharp-interference immersed-boundary methodology 
combined with a second-order accurate fraction step method. Their results indicated that 
the three dimensional and unsteady flow fields near the hinge area were the major risk for 
platelet aggregation and thrombosis during systole. Their results suggested that the design 
of the leaflet ear, the upstream section of the leaflet edge, and the hinge recess wall 
curvature is of particular importance in achieving better hemodynamic performance and 
less thromboembolic complications for prosthetic heart valves. Smadi et al studied the 
pulsatile blood flow pattern through a dysfunctional mechanical heart valve (Smadi et al., 
2010). They constructed five 2D numerical models with 0%, 25%, 50%, 75%, and 100% 
malfunction by Fluent 6.3.26 to study the velocity field, vortex formation and potential 
negative effects on blood components at the flow downstream. The results showed that 
the downstream of the malfunctioned valve, both the flow velocity and shear stress 
increased abnormally and there was a large number of vortices formation, which would 
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lead to the damage of the blood cells. These results indicated that the lateral velocity is as 
important as the central velocity, in the case of a dysfunctioned heart valve. King et al 
studied the effect of two leaflet opening angles on time-dependent 3D flows through a 
bileaflet mechanical heart valve (King et al., 1997). They constructed transient laminar 
3D CFD models to study the hemodynamic performance of the bileaflet valve opening at 
78 and 85 degree. The results indicated that the smaller the angle between leaflets the 
more shed vortices and flow separation would form, as well as higher shear stress. The 
results suggest that the orifice area for the central flow is also a very important factor to 
be considered for the valve design. Indeed, CFD models can provide detailed information 
on flow fields around the heart valves, and provide insight into new valve designs.        
2.5 Platelets and prosthetic heart valves 
Platelets are blood cells that look like flattened discs, with an average diameter of 
4 µm and a thickness about 1 µm. Platelets usually circulate for 9 to 12 days before being 
digested by phagocytes. The average concentration of platelets in blood is roughly 
350,000/µl. Platelets play an important role in hemostasis and thrombosis. They are the 
most important players in coagulation. .  
 Platelets are sensitive to mechanical forces, non-physiology flow patterns or 
contact with foreign materials. Flow factors that can cause the platelet activation include 
high shear and deformation rate, turbulence, and recirculation. Activated platelets enlarge 
in size and their shape become irregular with pseudopods sticking out. They express 
negative charge on their surface and release a lot of coagulant proteins from alpha 
granules and dense bodies. Among many other activation proteins, P-selectin are 
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expressed on activated platelet surface, and is usually considered platelet activation 
marker.  
Implantation of MHV into a human heart can alter the fluid dynamics and induce 
platelet activation (Bluestein et al., 2004). Alemu et al studied the flow-induced platelet 
activation and damage accumulation in a mechanical heart valve by numerical simulation 
(Alemu and Bluestein, 2007). They found that on the pathways that platelets repeatedly 
pass through, they are exposed to increased stress around MHV leaflet and can be trapped 
in the wake of the valve. These will increase the potential of platelets activation. Smadi et 
al reported that the velocities and shear stress downstream of a dysfunctional valve 
increased abnormally as large numbers of vortices formed around the location (Smadi et 
al., 2010). All these factors can damage blood cells, especially platelets. Therefore, it is 
very important for us to pay attention to platelet behavior (especially platelet activation) 
when a new prosthetic heart valve is introduced.      
2.6 Red blood cells and prosthetic heart valves 
 Red blood cells (erythrocytes) are the most abundant cells in blood, accounting 
for about 99.9 percent of the formed elements. Red blood cells are flexible and they look 
like biconcave disks. A red blood cell can circulate in the body for 100-120 days before 
digested by macrophages. Hemoglobin is the major component and its primary function 
is to transport oxygen to tissues everywhere in the body. When the cell membrane of the 
red blood cell breaks, hemoglobin and other internal components are released into 
plasma. This is known as hemolysis. Hemolysis can lead complications like anemia, 
jaundice and congestive heart failure. 
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Hemolysis after PHV replacements has been recognized as one of the serious 
complications (Mecozzi et al., 2002). Elevated mechanical forces on red blood cells are 
known to be the primary cause of hemolysis in patients with PHVs. High shear stress, 
pressure changes, contact with foreign materials and turbulent flow can all cause 
hemolysis. Among these factors, turbulence flow through PHVs is known to be the major 
factor that causes hemolysis due to the  excessive shear force generated on the surface of 
red blood cells (Rodgers and Sabiston, Jr., 1969).  Garcia et al studied the mechanisms of 
hemolysis with mitral prosthetic regurgitation (Garcia et al., 1996). They found that 
hemolysis with prosthetic heart valves was related to the flow disturbance in the jet flow 
and high shear stress. They also suggested that hemolysis was not related to the site of 
origin of the regurgitation and types of PHV implanted. Mild hemolysis occurs quite 
often in  patients with PHV (Shapira et al., 2009). A study investigated on 170 patients 
with St. Jude Medical valves and 80 patients with Medtronic-Hall valves, and the results 
showed that the subclinical hemolysis rate was 51.2 percent for St. Jude heart valve and 
17.8 percent for Medtronic-Hall heart valves (Shapira et al., 2009).  
However, studies have shown that chance of hemolysis in patients with PHVs can 
be decreased by improving the design of heart valves (Maraj et al., 1998). Therefore, 
hemolysis should be used as a factor to determine the performance of a newly designed 
PHV. 
CHAPTER III 
 
 
MATERIALS & METHODS 
3.1 Flow chamber design 
3.1.1 Design of the flow chamber 
 The goal of this study was to build a biocompatible flow chamber similar to a left 
ventricular assist device to study hemodynamic performance of PHVs. The materials 
chosen to construct the flow chamber must be biocompatible. Ideally, the flow chamber 
would provide a similar flow environment to that of a heart. The flow chamber consists 
of three major parts: water chamber, testing fluid chamber (for whole blood, plasma and 
washed platelets), and transparent valve sockets.  
3.1.2 Computer aided design (CAD) of flow chamber 
 We designed the three-dimensional water chamber, testing fluid chamber, and 
transparent valve sockets by using CAD software Pro-E Wildfire 4.0 PTC. A key design 
of the flow chamber was that the connections of the parts have to be as smooth as 
possible to minimize turbulent flow. Based on the computer aided design, the physical 
flow chamber was fabricated at OSU Physics machine shop.   
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3.1.3 Testing fluid chamber 
The testing fluid chamber was the most important part in the flow chamber 
because this was the location where whole blood, plasma or washed platelets were stored 
and circulated. It serves as the left ventricle in the human heart. The testing fluid chamber 
was made from Teflon (Regal Plastic). From outside, the testing fluid chamber looks like 
two flat cylinders stacked together (Figure 3.1). The bigger (bottom) cylinder had a 
diameter of 6 inches and the smaller (top) cylinder had a diameter of 4.6 inches. The 
thickness of the bigger cylinder was 0.78 inches and smaller cylinder 1.18 inches. On the 
inside of the chamber, it was shaped as a half sphere with a diameter of 3.7 inches. The 
volume of the semispherical space was about 7.75 cubic inches which was equivalent to 
127 milliliters. Two holes (1 inch in diameter) were drilled all the way through the 
semispherical space. These holes served as channels for testing fluid to circulate through 
PHVs. In each channel, a step with a height of 0.125 inch and a diameter of 1.315 inch 
was made for the placement of a PHV.  An O-ring groove (4.28 inches external diameter, 
0.13 thickness) at the opening of the semi sphere provided room for a sealing o-ring. 
Similarly, two O-rings were placed on the valve steps to prevent leaking.  Six screw holes 
(0.25 inches) were made on the bottom cylinder, to connect it with the water chamber.  
On the top cylinder, 6 screws holes (0.20 inches) were drilled for the connection with the 
Valve Sockets. Figure 3.2 shows the detailed dimensions of the testing fluid chamber. 
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 Figure 3.1: 3D CAD model of the testing fluid chamber. (A) The top surface of the 
testing fluid chamber. (B) The bottom surface of the testing fluid chamber. 
 
Figure 3.2: 2D CAD model of the testing fluid chamber with detailed dimensions. 
Figures are presented as the top, front, right hand and isometric views.  
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3.1.4 Water chamber 
 The water chamber had a similar design compared to the testing fluid chamber. 
This was the place where water is stored and connected to the reciprocating pump. Since 
this chamber does not have any contact with blood, plasma or blood cells, biocompatility 
is not required for the chamber material. However, for convenience, Teflon was used to 
build the housing of the water chamber as well. The inside and outside structures of the 
water chamber are the same as that of the testing fluid chamber as described above 
(Figure 3.3). On the bottom of the water channel, there were two threaded channels, to 
connect to two PVC pipes (average inner diameter 1.033”, average outer diameter 1.315”, 
Alsco Industrial Products, Inc.) The PVC pipes were threaded externally at one end and 
internally at the other. The externally-threaded end was connected to water chamber, 
while internally-threaded was connected to Brass Tapped Hose Adapter (A-665, ¾” MH 
x ¾” MIP x ½” tapped FIP, Lowe’s). Teflon tape was used on the threaded surfaces to 
prevent leaking. Clear PVC was chosen because it can provide the visibility of the water 
flow and simplify the task of water filling. Six holes were made on the water chamber to 
match the holes on the testing fluid chamber so the two chambers could be attached 
together. Figure 3.4 provides the dimensions of the water chamber. 
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 Figure 3.3: 3D CAD model of water chamber. (A) The top surface of the water chamber. 
(B) The bottom surface of the water chamber. 
 
Figure 3.4: 2D CAD model of water chamber with detailed dimensions. Figures are 
presented as the top, front, right hand and isometric views.  
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3.1.5 Transparent valve socket 
A transparent valve socket was connected to the top surface of testing fluid 
chamber and consisted of two small spaces to place PHVs. The two major parts of 
transparent valve socket were a clear plate and a pair of clear connecting tubings. Clear 
plate (Figure 3.5) was made from transparent PVC and the dimensions were 4 inches 
long, 2.5 inches wide, and 0.65 inches thick. There were two 1.125-inche holes in the 
middle of the plate and they were 2 inches apart, measuring from the center of the holes. 
The depth of the two holes was 0.25 inch.  Two slightly bigger holes with a diameter of 
1.315 inches with same centers were made at the bottom of the plate and the depth of 
these holes was 0.4 inches.  Six holes that match the threaded holes on the surface of 
testing fluid chamber were made on the plate so that the plate and the testing fluid 
chamber can be screwed together. Figure 3.6 shows the 2D CAD design of clear plate 
with detailed dimensions. Clear connecting tubings (Figure 3.7) were made from clear 
PVC with a length of 1.5 inch. The internal diameter of the tubings was 1 inch. One 
Female Luer (female Luer thread style with ¼” Hex, Small Parts) connector was placed 
on each connecting tubing for filling and sampling. Figure 3.8 shows the 2D CAD design 
of clear connecting tubing with detailed dimensions. The transparent valve socket (Figure 
3.9) was the combination of the clear connecting tubings and the clear plate. Both clear 
connecting tubings would insert into the holes of the clear plate. Figure 3.10 shows the 
2D CAD design of transparent valve socket (combination of clear connecting tubings and 
clear plate) with dimensions. 
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 Figure 3.5: 3D CAD model of clear plate. (A) The top surface of the clear plate. (B) The 
bottom surface of the clear plate. 
 
Figure 3.6: 2D CAD model of clear plate with detailed dimensions. Figures are presented 
as the top, front, right hand and isometric views.  
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 Figure 3.7: 3D CAD model of clear connecting tubing. (A) The top surface of the clear 
connecting tubing. (B) The bottom surface of the clear connecting tubing. 
 
Figure 3.8: 2D CAD model of the clear connecting tubing with detailed dimensions. 
Figures are presented as the top, front, right hand and isometric views. 
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 Figure 3.9: 3D CAD model of transparent valve socket. (A) Shows the top surface of the 
transparent valve socket. (B) Shows the bottom surface of the transparent valve socket. 
 
Figure 3.10: 2D CAD model of the transparent valve socket with detailed dimensions. 
Figures are presented as the top, front, right hand and isometric views. 
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3.1.6 Valve housing, diaphragm, O-rings, and Penrose tubing 
Two St. Jude bileaflet mechanical heart valves (St. Jude Medical Inc.) were used 
as the control valves to test the dynamic performance of the flow chamber. The external 
diameter of the valve was 0.9913 inches without housing. The valve housing (Figure 
3.11) was made from clear PVC (same material as the clear connecting tubing) and 
constructed in a ring shape with a thickness of 0.25 inch. The internal diameter of the 
valve housing was 1 inch, which allowed for the valve to be placed within it; the external 
diameter of the valve housing was 1.315 inch, which allowed the housing to sit tightly 
between the testing fluid chamber and the transparent valve socket. The valves were 
slightly smaller than the internal diameter of the valve housing, so a Teflon tape was used 
to wrap around the valves to ensure better fitting between them. Figure 3.12 shows the 
detailed dimension of the valve housing.   
Diaphragm (Figure 3.13) of the flow chamber was made from Latex (Natural 
Latex Rubber Sheet, 0.025” thickness, Small Parts, Inc.). It was made to fit between the 
testing fluid chamber and the water chamber. Figure 3.14 shows the 2D CAD design of 
diaphragm with detailed dimensions. 
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 Figure 3.11: 3D CAD model of the valve housing. 
 
 
Figure 3.12: 2D CAD model of valve housing with dimensions and top, front, right hand 
and isometric views.  
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 Figure 3.13: 3D CAD model of the diaphragm. 
 
 
Figure 3.14: 2D CAD model of diaphragm with dimensions and top, front, right hand and 
isometric views.  
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The flow chamber had a total of five O-rings to prevent leaking. Two different 
sizes of O-rings were used: one bigger O-ring (internal diameter 4”, external diameter 
4.25”, Small Parts) was placed between the testing fluid chamber and the water chamber; 
four smaller O-rings (internal diameter 1.125”, external diameter 1.25”, Small Parts) 
were placed between the testing fluid chamber and the valve housing, and between the 
valve housing and the transparent valve socket. 
A 5.5-inch surgical Penrose tubing (Penrose Drain, 1” x 0.12” x 18”, GF Health 
Products, Inc.) was used to connect the inlet and outlet of the testing fluid chamber.  
3.1.7 Assembly 
  All the parts described above were assembled by screws and clamps. Two 
different sized screws were used. Six big screws (vented socket cap screw, inch thread 
size: ¼”-20, length: 1- ½”, McMaster-Carr) were used to attach the testing fluid chamber 
and the water chamber. Stainless steel washers (round hole washer, internal diameter ¼”, 
external diameter 0.6”, McMaster-Carr) were used. Six small screws (vented socket cap 
screw, inch thread size: 10-32, length: 1”, McMaster-Carr) were used to attach the 
transparent valve socket and the testing fluid chamber.  
Silicon tubing (Peroxide-cured silicon tubing, internal diameter: ½”, external 
diameter: 5/8”, Cole-Parmer) was used to connect the flow device to the reciprocating 
pump (Harvard Apparatus Pulsatile Blood Pump for Large Animal, Harvard Apparatus) 
through the water chamber inlet/outlet. One end of the silicon tubing was connected to a 
brass machine female hose nut (½” FH x ¾” Flare, Lowe’s). This fitting had a threaded 
adapter that can fit into the nipple of the water housing and the other end can fit in with 
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the silicon tubing that was connected to the reciprocating pump. In order to prevent 
leaking, when the pressure changed, hose clamps were used at the connection between 
the pump and the tubing. Stainless steel hose clamps (Murray #8 adjustable clamp, 
Lowe’s) were used on the connection of silicon tubing and brass hose barbs;  and acetal 
hose clamps (acetal snapper type hose clamp, for 5/8” outer diameter, 0.569-0.65 clamp 
internal diameter) were used on the connection of silicon tubing and the nozzle of the 
pump. Other bigger acetal hose clamps were placed at the connection between clear 
connecting tubing and Penrose tubing to prevent leaking when whole blood or plasma 
were circulated in the system. Figure 3.15 shows the assembling of all the components. 
Figure 3.16 shows the CAD assembled of the flow chamber. Figure 3.17 shows the 
desired flow direction in the flow device.  
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Figure3.15: CAD model of assembling of different components.
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 Figure 3.16: 3D CAD model of the assembled flow chamber
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Figure 3.17: Desired flow direction in the flow chamber. Thin blue arrows indicate the flow direction of water and thick red arrows 
indicate the flow direction in the testing fluid chamber. 
 
 
3.2 In vitro studies 
3.2.1 Biocompatibility of the flow chamber towards washed platelets  
  Both foreign materials and altered shear stress induced by disturbed flow can 
trigger platelet activation. Therefore, platelet activities within the flow chamber was the 
first to be examined, under both static and dynamic conditions.  
3.2.1.1 Platelets preparation 
 Platelet rich plasma (PRP) was obtained from Oklahoma Blood Institute. To make 
washed platelets, PRP was centrifuged at 1000xg for 9 minutes. Cell pellets were 
resuspended in platelet buffer, which contains 135 mM NaCl, 5 mM D-(+)-Glucose, 2.7 
mM KCl, 0.5 mM Na2HPO4, 1 mM MgCl2, 1 mM Sodium Citrate, 0.1% Bovine Serum 
Albumin, and 10 mM HEPES (pH 7.4, adjusted by adding NaOH). The final 
concentration of washed platelets was 100,000 cells/µl.   
3.2.1.2 Platelet activation (CD62P expression) under static conditions 
 Before filling washed platelets into the testing fluid chamber, the flow system was 
rinsed with distilled water and platelets buffer for about 5 minutes. After that, washed 
platelets were filled into the testing fluid chamber through the filling port (with the 
sampling port open to remove the air bubbles). After all air bubbles were removed, both 
the sampling and filling ports were closed. For 5 hours, 10 ml platelet samples were taken 
every hour from the testing fluid chamber (the chamber was gently shake to prevent 
platelet settling) for P-selection expression measurement. To measure P-selection 
expression, FITC conjugated murine anti human CD62P (Ancell Corp.) (1:50) antibody 
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was added to platelet samples (100 µl) and incubated at room temperature for 30 minutes. 
Then 400µl of platelet buffer was added to each sample and analyzed by flow cytometry.  
Washed platelets that were kept in a test tube (without exposure to the flow chamber) 
served as the negative control. Positive control was achieved by Ionophore A23187 (200 
µM, 5 minutes at 37ºC). 
3.2.1.3 Platelet activation under dynamic conditions 
 The setup of dynamic experiments was similar to that of static experiments except 
that two St. Jude bileaflet mechanical heart valves were placed oppositely in the system 
to control flow direction. The water chamber was filled with water and connected to a 
Harvard reciprocating pump. About 250 ml washed platelets (100,000/µl) were placed in 
the testing fluid chamber. The flow rate of the system was fixed at 5 L/min with a stroke 
volume of 80 ml and stroke rate of 72 min-1. The systolic/diastolic ratio was fixed at 
0.375. The experiment was for 90 minutes and platelet samples were taken out from the 
circulation every 15 minutes by syringe through the sampling port. Platelet surface P-
selectin expression was measured as discussed above. On average, one platelet stays 
approximately 7 days in circulation and passes through the aortic valve once every 90 
seconds in its lifetime (Bluestein et al., 2004). Therefore, it is about 6700 valve passages 
for a normal platelet in its lifetime. The time chosen for the dynamic experiments was 90 
minutes, corresponding to 8400 passages through the valves. The passages of the platelet 
in the chamber were sufficient to test the platelet activity in vitro.  
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3.2.2 Hemolysis measurement under static conditions 
 Biocompatibility of the red blood cells towards the testing fluid chamber was 
tested through hemolysis. Fresh whole blood (with dextrose, EDTA and Sodium citrate) 
was obtained from Oklahoma Blood Institute. 250 ml whole blood was placed into the 
testing fluid chamber under static conditions. 10 ml of blood samples were taken from 
sampling port every hour. Hemolysis was measured using a spectrophotometer (Beckman 
Coulter) at 540 nm. The hemoglobin concentration was calculated by:  
Hemoglobin concentration = absorbance x concentration of hemoglobin 
standard/absorbance of hemoglobin standard, where the absorbance values were obtained 
from spectrophotometer measurements, and the hemoglobin standard (11.6g/dl) was 
purchased from Pointe Scientific Inc. Whole blood that was not exposed to the flow 
chamber served as negative control. Positive control was achieved by homogenizing 
whole blood (at 20,000 RPM, 55 Hz for 30 sec).  
3.2.3 Red blood cells dynamic test 
    Similar experiments were conducted under dynamic conditions. For this set of 
experiments, two St. Jude bileaflet mechanical heart valves were placed in the testing 
fluid chamber to control flow direction.  The experiment was run for 90 minutes and 10 
ml of blood samples were taken from the sampling port every 15 minutes by a syringe. 
Hemolysis was measured and blood hemoglobin concentration was calculated as 
previously described.   
  At the end of the each experiment, all the components and valves were cleaned 
with caution. The flow chamber was dissembled to separate pieces and the valves were 
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taken from housing as well. Every single part was rinsed thoroughly with large amounts 
of distilled water, followed by 10% of bleach. After that, all the parts were rinsed with 
large amounts of distilled water again and washed with 0.01 M HCL. At the end, all parts 
were rinsed again with distilled water to ensure they were thoroughly cleaned. Penrose 
tubing was discarded after each use.    
3.3 Numerical simulation 
3.3.1 3D numerical model of the testing fluid chamber 
 The model of the flow device was constructed in ANSYS ICEM CFD 12.0. In this 
study we developed a 3D numerical model of the testing fluid chamber (the only part that 
is in contact with blood or plasma) with St. Jude bileaflet mechanical heart valves in the 
device to examine the fluid dynamics of the system. 
 The dimensions and geometrical information were based on the models 
constructed in Pro-E. The simulation was aimed to mimic and help us to visualize the 
realistic flow conditions in the flow chamber. The original driving force of the chamber 
circulation came from the reciprocating pump, whose movement induced a pressure 
difference in the water chamber, which in turn caused the flexible diaphragm to move up 
and down. The movement of the diaphragm caused the opening and closing of the heart 
valves, i.e., the circulation in the testing fluid chamber. Therefore, only the diaphragm, 
semispherical space of the testing fluid chamber, and the two flow channels with the 
valves were included in the model. The diaphragm was defined as the inlet of the fluid 
chamber and the two valves were constructed in fully opened or fully closed position. 
The maximum angle (compared to the horizontal plane) for the fully opened valve was 10 
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degree and the maximum closing angle was 85 degree (Figure 3.18). Two half circles 
(0.05 inches diameter) were used to mimic the hinge area of the St. bileaflet valve (Figure 
3.19). Five dynamic positions were used to monitor the flow conditions during the outlet 
valve opening: when 0, 20, 40, 60, and 80 ml of fluid was pushed out the outlet valve. 
Table3.1 listed the height of the diaphragm with different volume change.  
 
Figure 3.18: 3D numerical model of the testing fluid chamber. (A) 3D model of the flow 
system. (B) Valve location in the system, one valve was at fully opened position and the 
other valve at fully closed position. 
 
Figure 3.19: 3D model of fully closed valve with two small hinge areas at both ends. 
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Table 3.1- Diaphragm height (from equilibrium location) and the number of elements in 
different volumes. 
 
Volume (ml) Diaphragm height (inch) Number of elements 
0 0 781,207 
20 0.17 782,083 
40 0.34 781,535 
60 0.51 777,681 
80 0.68 776,801 
 
3.3.2 Meshing 
 The model with the above discussed geometry was meshed with hybrid mesh 
using hexahedral and tetrahedral elements in ANSIS ICEM CFD 12.0.1. The areas of 
valves and the surfaces between the two channels and chamber were finely meshed 
because these were the regions of interest (total elements-298,562, average element size-
0.03 inches). The reason of having different mesh sizes in the model was to compensate 
for the technical insufficiency of computational memory, especially when turbulent 
solver was used. Table 3.1 also shows the complete list of element numbers at different 
volume and diaphragm height. All results from the simulation were proved to be 
independent of mesh density. Figure 3.20 shows the meshing of the fluid chamber (at 
volume = 0 ml) and one valve (with two leaflets). 
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 Figure 3.20: (A) Meshing of the testing fluid chamber with diaphragm at 0” height. (B) 
Meshing of the valve leaflets when the fully open position. 
 
3.3.3 Computational fluid dynamics 
3.3.3.1 Basic theory 
  The fundamental theory of computational fluid dynamics (CFD) is governed by 
Navier-Stokes equations. The basic idea is to transform the flow domain into finite 
numbers of small computational elements and apply Navier-Stokes equations to every 
single element. Every element in the entire domain would have a solution and the 
computational calculation would keep calculating until it reached the required accuracy 
(convergence criteria for velocity components-1.0E-04, continuity-1.0E-04). Navier-
Stokes equations are derived from Newton’s Second Law, conservation of mass. The 
general form of fluid motion equation is: 
ߩ ቀడ௩
డ௧
൅ ݒ · ׏ݒቁ ൌ ߩ݃ െ ׏݌ ൅ ׏ܶ  (3.1) 
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where ߩ is fluid density, ݒ is fluid velocity, ݃ is gravitational force, ݌ is pressure, and ܶ is 
tensor. 
 For incompressible Newtonian fluid with constant viscosity, the equation further 
changes to a vector form: 
ߩ ቀడ௩
డ௧
൅ ݒ · ׏ݒቁ ൌ ߩ݃ െ ׏݌ ൅ µ׏ଶݒ  (3.2) 
where ߤ is fluid viscosity. In our case, blood or plasma to be tested in the testing fluid 
chamber were considered incompressible fluids. 
  The Cartesian form of the equation can be written as the following: 
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where ݑ, ݒ , and ݓ  are the velocities on x, y, and z direction in Cartesian coordinate 
system, and g is the gravitational force. 
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3.3.3.2 Laminar flow model 
 The flow field in the numerical model was firstly estimated by laminar models, to 
check the validity of model structure and geometry, meshing as well as the basic flow 
patterns. The viscosity is 1 cP, the inlet velocity was given in Table 3.2, and boundary 
conditions were discussed in the following section.   
3.3.3.3 Turbulent flow model 
 To examine the complex flow patterns in the testing fluid chamber, a k-ω 
turbulent model was used. Reynolds number was obtained for the whole flow field to 
examine if turbulence exists in the chamber under dynamic flow conditions. 
3.3.4 Flow analysis 
 The meshed models of the fluid chamber form ANSYS ICEM CFD 12.0.1 was 
imported to ANSYS CFX-Pre 12.0 for boundary setup and surface definition. Every 
element was checked for proper meshing (CFX-Pre 12.0). The model was simulated by 
ANSYS CFX-Solver Manager 12.0 and exported to ANSYS CFD-Post 12.0 for the 
results. 
Assumptions: 
The following assumptions were used to solve the numerical model: 
• Fluid Medium: Water was defined as the fluid medium in both the laminar and 
turbulent flow model.  
• Inlet Velocity: The flow was fully developed before entering the chamber. 
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Boundary conditions: 
The boundary conditions were defined as the following: 
• Inlet: During systole, fluid was pushed out of the outlet valve, so diaphragm was 
defined as the inlet surface. The complete list of velocities at different chamber 
volume was given in Table 3.2. Outlet: The outlet surfaces were defined as 
pressure outlets.  
• Walls: Housing, channels, and valve leaflets were defined as rigid walls. During 
diastole, fluid was pushed into the fluid chamber through the inlet valve, so the 
diaphragm was defined as a rigid wall.  
• Turbulent parameters: Turbulent intensity was defined as 3% in the turbulent 
model. 
• Steady condition: The simulation was run under the steady condition.   
Table 3.2-The different inlet velocity of systolic/diastolic at different volumes. 
 Systolic Diastolic 
Volume (ml) Inlet Velocity (cm/s) Inlet Velocity (cm/s) 
0 0 0 
20 0.3460 4.7365 
40 0.6919 9.4731 
60 1.0379 14.2096 
80 1.3839 18.9458 
 
CHAPTER IV 
 
 
RESULTS 
4.1 Flow chamber 
 After the design of the flow chamber in Pro E has been completed, all the 
components were fabricated at OSU physics machine Shop. All the components were 
manufactured following the dimensions designed in Pro E. Figure 4.1 shows all the 
finished components and some readymade parts used in the flow chamber. The volume of 
both the water and the testing fluid chamber was about 125 ml, which was close to the 
desired volume. The two channels (inlet and outlet) in the testing fluid chamber each had 
1-inch diameter, which perfectly matched the size of the valves. All the components were 
put together by screws. Teflon tape was used to wrap around the valves to ensure a better 
fitting into the valve housing. Figure 4.2 shows the assembled flow chamber with the 
valves. 
Silicon tubing was used to connect the flow chamber to the pump. One end of the 
silicon tubing with the female hose adapter was used to connect with the water chamber 
and the other end was connected to the nozzle of the pump. There was a T-connector in 
one of the silicon tubings to provide an extra path for the water filling port. 
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All the connections were fixed by stainless steel hose clamps. Figure 4.3 shows the setup 
of the connecting silicon tubing.   
 Before each dynamic experiment, the system was assembled properly as designed. 
Then it was connected to the pump through the silicon tubing and water was slowly filled 
into the water chamber from water filling port until the water chamber was full (no more 
bubbles). Washed platelet or whole blood was then filled into the testing fluid chamber 
through the filling port with the sampling port open to remove bubble. The assembled 
system is shown in Figure 4.4. 
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 Figure 4.1: Finished components and readymade parts of the flow chamber. (A) Water 
chamber. (B) Testing fluid chamber. (C) Transparent valve socket. (D) From left to right, 
valve housing, St. Jude bileaflet mechanical heart valve, and valve with housing. (E) 
Diaphragm and different sizes of O-rings.  (F) Screws and washers. (G) Folded Penrose 
tubing. (H) Acetal clamps with different sizes. (I) Luer fittings inserted at filling and 
sampling ports.  
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 Figure 4.2: Assembled components. (A) Installation of the valves in the fluid chamber 
before transparent valve socket was connected. The valves were placed on opposite side 
of the channel to control flow direction. (B) Final assembled of the flow chamber with 
the penrose tubing tied with acetal clamps and Luer fittings inserted in the sampling and 
filling ports.  
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 Figure 4.3: The tubing to connect the reciprocating pump and the flow chamber, which 
was made from Silicon. (A) Filling port of the water chamber and pump. (B) Locations 
where the tubings connected to the pump and were fixed by Acetal clamps to prevent 
leaking. (C, D) Brass machined female hose nut to hose barbs connected to water 
chamber. (E) T-connector connected to pump, water chamber, and water filling port.  
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Figure 4.4: Complete experimental setup with a stand to hold the flow chamber. The stand was made from ½ " PVC tubing. The 
camera was used to record the experiment to observe the valve movements. 
 
 
4.2 Results from in vitro experiments 
4.2.1 Platelets activation experiments (CD62P expression) 
4.2.1.1 Platelet activation measurement under static conditions 
 CD62P expression on platelets that were placed in the flow chamber was 
compared to that from control platelets (platelet sitting on bench without any treatment). 
Due to the variance in platelet activation from different donors and on different days, 
CD62P expression from both control platelets and flow chamber platelets were 
normalized to that of control platelets at time 0. Figure 4.5 shows the typical flow 
cytometry results of CD62P expression on control platelets, platelets in the flow chamber, 
and platelets treated with Ionophore A23187 (positive control). Experiments under static 
conditions were repeated 6 times. Paired Student’s t-test was used to detect if there was 
any significant difference (P<0.05) between treated and control (bench) platelets.  The 
results indicated that the elongated contact with the Teflon testing fluid chamber and the 
latex diaphragm induced a significant increase in platelet surface CD62P expression 
(Figure 4.6) after 3 hour contact. While before 3 hours, the testing fluid chamber did not 
induce any platelet activation. Two-way ANOVA was also used to examine if there were 
any significant effects from treatment (bench or chamber) or time. The results 
demonstrated that both treatments and time affect platelet surface P-selectin expression 
significantly (P<0.05). Then two separate single-classification ANOVA and Student-
Newman-Keuls post-test were used to compare platelet activation at every time step 
when they were placed in the chamber or on the bench. The results indicated that without 
treatment (bench), platelet activation did not change with time. While in the flow 
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chamber, platelet activation at 5 hours was significantly different from that at 1, 2 and 3 
hours, matching the Student’s t-test results reported above.   
 
Figure4.5: Flow cytometry results of CD62P expression on control platelets and platelets 
in flow device at 5 hours. A23187 was Ionophore that used to activate platelets. 
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 Figure 4.6: The platelet activation between bench and chamber during 5 hours of static 
experiments. Washed platelet with the concentration of 100,000/µl was taken every hour 
from bench and chamber for P-selectin measurement. It shows CD62P Expression ± 
SEM, normalized to the bench CD62P expression at time 0. The data demonstrated that 
no significant change of CD62P expression in the first 2 hours but a detectable change of 
CD62P expression from 3 hours. The difference between the two was significant (n=6, * 
- P < 0.05 by paired Student’s t-test). 
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4.2.1.2 Platelet activation measurement under dynamic conditions 
 CD62P expression was measured on control platelets and platelets that were 
placed in the flow chamber under dynamic conditions.  All data were normalized to that 
of control platelets at time 0. Figure 4.7 demonstrated that circulation in the flow 
chamber through the two St. Jude bileaflet mechanical heart valves did not induce any 
significant change in platelet activation. Again, paired Student’s t-test and two-way 
ANOVA were used to conduct the statistical analysis.  
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 Figure 4.7: Platelet activation comparison between bench and chamber during 90 minutes 
of dynamic experiments. Washed platelet with the concentration of 100,000/µl was taken 
every 15 minutes from bench and chamber for P-selectin measurement. It shows CD62P 
Expression ± SEM, normalized to the bench CD62P expression at time 0. The data 
demonstrated that no significant change of CD62P expression over the period of 90 
minutes in 15 minutes intervals (n=6). 
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4.2.2 Hemolysis measurements 
4.2.2.1 Hemolysis measurement under static conditions 
  A comparison study of blood hemolysis of control (bench) red blood cells and 
red blood cells that were placed in the testing fluid chamber under static conditions was 
conducted. Both control and chamber blood sample absorbance was measured by 
spectrophotometer at 540 nm. Hemoglobin concentration (g/dl) in whole blood was 
determined based on the formula below: 
஺௕௦௢௥௕௔௡௖௘ ௢௙ ௌ௔௠௣௟௘
஺௕௦௢௥௕௔௡௖௘ ௢௙ௌ௔௧௡ௗ௔௥ௗ
ൈ ܥ݋݊ܿ݁݊ݐݎܽݐ݅݋݊ ݋݂ ܵݐܽ݊݀ܽݎ݀ ሺ݃ ݈݀ൗ ሻ ൌ ܪ݁݉݋݈݃݋ܾ݅݊ሺ
݃
݈݀ൗ ሻ 
 (4.1) 
where the absorbance of standard is the absorbance from hemoglobin standard, the 
concentration of standard is equal to 11.6 g/dl, and absorbance of sample is the 
absorbance from the sample. 
 All measured values of control and chamber blood samples were applied to the 
formula (4.1) to calculate the hemoglobin concentration. Both bench and chamber 
hemoglobin concentrations were normalized by the bench hemoglobin concentration at 
time 0. Figure 4.8 demonstrates the comparison between the bench blood samples and 
chamber blood samples for 6 hours. The data was examined by paired Student’s t-test and 
two-way ANOVA. The results showed that no statistically significant difference 
significance was detected in hemolysis between control and chamber blood samples. In 
this set of experiments, measured hemoglobin concentration varied between 14.71 g/dl 
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and 17.45 g/dl (only male blood was used), and the normal hemoglobin concentration is 
11-16 g/dl for adult female and 13-18 g/dl for adult male.  
 
Figure 4.8: The hemolysis between bench and chamber during 6 hours of static 
experiments. Whole blood was taken every 1 hour from bench and chamber for 
absorbance measurement at 540 nm. It shows hemoglobin concentration ± SEM, 
normalized to the bench hemoglobin concentration at time 0. The data demonstrated that 
no significant change of hemolysis over the period of 6 hours in every hour intervals 
(n=5). 
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4.2.2.2 Hemolysis measurement in dynamic experiments 
 Similar experiments were conducted under dynamic conditions. Whole blood was 
circulated in the testing fluid chamber for 90 minutes and samples were taken out every 
15 minutes for hemoglobin concentration measurement using a spectrophotometer at 540 
nm. Blood samples that were not treated were used as the negative control. Both control 
and chamber hemoglobin concentrations were normalized by the control hemoglobin 
concentration at time 0. Paired Student’s t-test was used to detect if there was any 
significant difference between bench blood samples and chamber blood samples. The 
results (Figure 4.9) indicated that there was no statistically significant difference between 
control blood and that were circulated in the testing fluid chamber. Two-way ANOVA 
was used to further investigate the effects on hemolysis from treatment (bench or 
chamber) and time. The results demonstrated that only time has effect. Therefore, a 
single-classification ANOVA followed by Student-Newman-Keuls post-test were used to 
compare every timed sample for bench and chamber blood. The results indicated there 
was no significant change in hemolysis induced by time. However, paired t-test showed 
that bench blood samples had a significantly increased hemoglobin concentration at 15, 
30, 45, and 90 minute compare to bench. Since hemolysis induced by chamber was lower 
than that in the control blood at those time points, we can conclude that the chamber did 
not induce any increase in hemolysis.  
In this set of experiments, measured hemoglobin concentration varied between 
12.25 g/dl and 17.75 g/dl (female blood); between 14.45 g/dl and 17.71 g/dl (male blood) 
indicating there was no hemolysis occurring during the dynamic experiments.  
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 Figure 4.9: The hemolysis between bench and chamber during 90 minutes of dynamic 
experiments. Whole blood was taken every 15 minutes from bench and chamber for 
absorbance measurement at 540 nm. It shows hemoglobin concentration ± SEM, 
normalized to the bench hemoglobin concentration at time 0. The data demonstrated that 
no significant change of hemolysis over the period of 90 minutes in every 15 minutes 
intervals (n=4). 
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4.3 Numerical results 
 CFD studies were conducted to examine the flow field in the testing fluid 
chamber with two St. Jude bileaflet mechanical heart valves.  During systole, fluid was 
pushed out of the outlet valve as the diaphragm moved up; during diastole, fluid was 
pushed into the chamber through the inlet valve as the diaphragm moved down. The 
model was conducted under both laminar and turbulent conditions. 
4.3.1 Laminar flow model 
 The main purpose of the laminar model was to examine if the geometry, structure 
and meshing were proper. The laminar model provided a general view of the flow 
patterns in the flow chamber and was used as the base for our turbulent model. 2D and 
3D velocity distributions were presented in Figure 4.10 through Figure 4.13.  
Figure 4.10 shows 2D velocity vectors of systole and diastole under laminar flow 
conditions in the testing fluid chamber. The maximum velocity during systole was 0.5086 
m/s (end of systole), while the maximum velocity during diastole was 0.4209 m/s (end of 
diastole). Figure 4.11 shows the 3D velocity vectors during systole and diastole under 
laminar flow conditions. Figure 4.12 shows velocity contours of the flow fields under 
both systolic and diastolic conditions. Figure 4.13 shows velocity stream lines in the 
chamber. All these results indicated that the highest velocity occurred near the valve 
region at the end of systole and diastole. Therefore, pressure difference (or gradient) 
across the valve was examined at that time. Figure 4.14 depicted the pressure distribution 
contour at the valve area. At the end of systole, the pressure difference across the open 
outlet valve was 57.2 Pa (0.43 mm Hg), and at the end of diastole, the pressure difference 
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across the open inlet valve was 37.8 Pa (0.28 mm Hg). The average pressure around the 
outlet valve at the end of systole was 21358.5 Pa (160.2 mmHg), while the average 
pressure around the inlet valve at the end of diastole was 10689.9 Pa (80.2 mmHg).  
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 Figure 4.10: Velocity vectors in the testing fluid chamber during systole and diastole 
under laminar conditions. Images are presented in 2D views. The left side of the figure 
shows the flow fields as the diaphragm was moving up with a 20ml increment (systole). 
The right side of the figure shows the flow fields as the diaphragm was moving down 
with a 20ml increment. Arrows indicate the sequence in occurrence.     
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 Figure 4.11: Velocity vectors in the testing fluid chamber during systole and diastole 
under laminar conditions. Images are presented in 3D views. The left side of the figure 
shows the flow fields as the diaphragm was moving up with a 20ml increment (systole). 
The right side of the figure shows the flow fields as the diaphragm was moving down 
with a 20ml increment. Arrows indicate the sequence in occurrence.     
63 
 
 Figure 4.12: Velocity contour in the testing fluid chamber during systole and diastole 
under laminar conditions. Images are presented in 2D views. The left side of the figure 
shows the velocity contour as the diaphragm was moving up with a 20ml increment 
(systole). The right side of the figure shows the flow fields as the diaphragm was moving 
down with a 20ml increment. Arrows indicate the sequence in occurrence.     
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 Figure 4.13: Velocity stream lines in the testing fluid chamber during systole and diastole 
under laminar conditions. Images are presented in 3D views. The left side of the figure 
shows the stream lines as the diaphragm was moving up with a 20ml increment (systole). 
The right side of the figure shows the flow fields as the diaphragm was moving down 
with a 20ml increment. Arrows indicate the sequence in occurrence. 
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Figure 4.14: Pressure distribution contours at the valve area during systole and diastole under laminar conditions. Images are presented 
in 2D views. The left side of the figure shows the pressure contour as the outlet valve was fully opened (systole). The right side of the 
figure shows the pressure contour as the inlet valve was fully opened (diastole). (1 Pa = 0.007501 mmHg)  
 
 
4.3.2 Turbulent flow model 
Based on the laminar model, a 3D k-ω turbulence model was conducted to 
examine the flow field in the testing fluid chamber. Similar flow patterns were observed 
with the turbulent model, compared to that of the laminar model. Flow patterns were 
presented in velocity distributions in Figure 4.15 through Figure 4.18.  Figure 4.15 shows 
the 2D velocity vectors during systole and diastole under turbulent flow conditions in the 
testing fluid chamber. The maximum velocity during systole was 0.5106 m/s (end of 
systole), while the maximum velocity during diastole was 0.4321 m/s (end of diastole). 
Figure 4.16 shows the 3D velocity vectors during systole and diastole under turbulent 
flow conditions. Figure 4.17 shows the velocity contours of the flow under both systolic 
and diastolic conditions. Figure 4.18 shows the velocity stream lines of the flow field in 
the chamber. Again, it was clear that the maximum velocity and biggest velocity gradient 
occurred at the end of systole and diastole around the valve area. Therefore, pressure 
distribution was examined (Figure 4.19). The results indicated that the average pressure 
around the outlet valve at the end of systole was 21357.3 Pa (160.2 mm Hg) and the 
average pressure around the inlet valve was 10691.6 Pa (80.2 mm Hg) at the end of 
diastole. For both systole and diastole conditions, the pressure difference across the open 
valve was similar to that observed under laminar flow conditions (53.8 Pa/0.40 mmHg 
for systole and 45.4 Pa/0.34 mmHg for diastole). 
To examine if turbulence existed under flow conditions, Reynolds number was 
calculated for every single fluid element. The highest Reynolds number occurred at the 
end of systole and the value was 2127.69. The average Reynolds number during systole 
was 558.23 and the average Reynolds number during diastole was 385.06. Table 4.2 
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summarized the minimum and maximum Reynolds number during systole and diastole 
when various volumes of fluid was ejected or filled into the testing fluid chamber.   
Table 4.1-Minimum and maximum Reynolds number in different systolic and diastolic 
volumes. 
 
Volume (ml) 
Systolic Diastolic 
Minimum Maximum Minimum Maximum 
20 0.0007 366.54 0.0824 308.39 
40 0.0031 765.63 0.0630 614.18 
60 0.0062 1205.96 0.1660 910.83 
80 0.0263 2127.69 0.1230 1247.11 
 
In summary, both the laminar model and the turbulent model demonstrated 
similar flow field and flow conditions in the testing fluid chamber. No turbulence was 
observed. The highest flow velocity (velocity gradient) occurred at the end of systole and 
diastole, while the associated pressure difference (gradient) was physical. Therefore, the 
results obtained from the numerical simulated demonstrated that the structure of the 
testing fluid chamber did not induce complex flow conditions and the flow environment 
generated by the chamber was suitable for heart valve dynamic performance studies.  
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 Figure 4.15: Velocity vectors in the testing fluid chamber during systole and diastole 
under turbulent conditions. Images are presented in 2D views. The left side of the figure 
shows the flow fields as the diaphragm was moving up with a 20ml increment (systole). 
The right side of the figure shows the flow fields as the diaphragm was moving down 
with a 20ml increment. Arrows indicate the sequence in occurrence.       
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 Figure 4.16: Velocity vectors in the testing fluid chamber during systole and diastole 
under turbulent conditions. Images are presented in 3D views. The left side of the figure 
shows the flow fields as the diaphragm was moving up with a 20ml increment (systole). 
The right side of the figure shows the flow fields as the diaphragm was moving down 
with a 20ml increment. Arrows indicate the sequence in occurrence. 
70 
 
 Figure 4.17: Velocity contour in the testing fluid chamber during systole and diastole 
under turbulent conditions. Images are presented in 2D views. The left side of the figure 
shows the velocity contour as the diaphragm was moving up with a 20ml increment 
(systole). The right side of the figure shows the flow fields as the diaphragm was moving 
down with a 20ml increment. Arrows indicate the sequence in occurrence.     
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 Figure 4.18: Velocity stream lines in the testing fluid chamber during systole and diastole 
under turbulent conditions. Images are presented in 3D views. The left side of the figure 
shows the stream lines as the diaphragm was moving up with a 20ml increment (systole). 
The right side of the figure shows the flow fields as the diaphragm was moving down 
with a 20ml increment. Arrows indicate the sequence in occurrence.
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Figure 4.19: Pressure distribution contours at the valve area during systole and diastole under turbulent conditions. Images are 
presented in 2D views. The left side of the figure shows the pressure contour as the outlet valve was fully opened (systole). The right 
side of the figure shows the pressure contour as the inlet valve was fully opened (diastole). (1 Pa = 0.007501 mmHg) 
 
 
CHAPTER V 
 
 
DISCUSSION 
In this study, we designed and fabricated a flow chamber to study the 
performance of prosthetic heart valves (PHVs). The biocompatibility of the flow chamber 
was tested through the responses from platelets (platelet activation, i.e. CD62P 
expression) and red blood cells (hemolysis). Both static and dynamic experiments with 
platelets and red blood cells were conducted. Also, the dynamic flow patterns inside the 
testing fluid chamber as investigated using numerical simulations.  
5.1 Flow chamber design 
 Compared to the commercially available left ventricular assist devices (LVADs), 
this custom-built flow chamber provided a more economic experimental setup to study 
the performance of PHVs. (Oz et al., 2003). The other major advantage of this flow 
chamber is that it can be used to study PHVs of different designs and different sizes. The 
major components of the flow chamber include a testing fluid chamber, a water chamber, 
and a transparent valve socket. Both the testing fluid and water chambers were made 
from Teflon. Teflon is a well known biocompatible material and has been used in many 
blood implantable devices. In some cases, Teflon had also been used to make some parts 
of implantable heart devices (Akutsu and Kantrowitz, 1967). 
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The testing fluid chamber was carefully designed such that the chamber volume (127 ml) 
matched physiological end diastolic volume, 130 ml.  
The Water chamber was connected to an external reciprocating pump (Harvard 
Apparatus Pump) which was used widely to provide physiologically relevant flow 
environments (Bluestein et al., 2004). The pump setting can be adjusted in order to mimic 
the flow rate, stroke volume (80 ml), stroke rate (72 min-1,) and systolic/diastolic ratio 
(0.375), etc. of a normal human heart. The ability of the pump to replicate physiological 
flow conditions provided a desirable environment for in vitro experiments. The testing 
fluid chamber and the water chamber were separated by a diaphragm, whose movement 
drove the flow in the testing fluid chamber by transmitting the pressure gradient from the 
water chamber. In dynamic experiments, the diaphragm was subjected to a maximum 
deformation of 0.68 inches (in height) for about 6,500 times (in 90 minutes). So, the 
thickness of the diaphragm was chosen at 0.025 inches, which can undergo a 750 percent 
elongation and withstand up to 4,000 psi of tensile strength. The mechanical property of 
the chosen diaphragm was strong enough to withstand the loading conditions required by 
the experiments.  
The transparent valve socket was designed to hold two heart valves at the other 
end of the testing fluid chamber. The socket was made from PVC. PVC has been widely 
used in biomedical applications. It is one of the most common materials used for 
catheters (Spilezewski et al., 1988). In addition, clear PVC was selected so as to enable a 
direct visualization of the movement of the valves. Inside the socket, the two valves were 
placed parallel to each other but in opposite directions to control flow direction. The 
valve used in this study was the St Jude bileaflet mechanical heart valve, which was the 
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most commonly used mechanical heart valve in the US market. Since St. Jude bileaflet 
mechanical heart valves were well designed and would not induce flow disturbance, the 
experiments with these valves (control valves) were able to help us to evaluate the 
performance of the flow chamber and its direct effect on the flow field. The socket was 
tailor made to house the valves that are under consideration, so as to provide a smooth 
flow without any disturbance. The smooth and non-turbulent design of the testing flow 
chamber and valve holder provided a suitable dynamic environment to study valve 
functions.  
5.2 Experimental studies 
 PHVs are primarily in contact with blood and so their performance greatly 
depends on the compatibility with platelets and red blood cells. In other words, PHVs 
should not induce any damage to red blood cells (hemolysis) or activate platelets. In this 
study, we measured platelet activation and hemolysis induced by the flow chamber under 
both static and dynamic conditions. 
 Hemolysis is the breaking of the red blood cell membrane and the release of 
hemoglobin into to the blood. During hemolysis, the concentration of the red blood cells 
(hemoglobin) decreases in blood which reduces the oxygen supply. Hemolysis has been 
used as a standard to determine the performance of PHVs or similar devices (Mecozzi et 
al., 2002). In our experiments, at different time points, the hemoglobin concentration in 
whole blood inside the testing fluid chamber was measured by a spectrophotometer at an 
absorbance wavelength of 540 nm. Our results demonstrated that under static conditions, 
there was no significant (n=5) change in hemoglobin concentration for a period of 6 
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hours. This indicated that the flow device did not induce hemolysis. The results obtained 
from dynamic experiments indicated that the addition of the St. Jude bileaflet mechanical 
heart valves and the dynamic flow environment induced significant (n=4) changes in 
hemoglobin concentration by using pair t-test, after blood was circulated in the device for 
90 minutes, compared to the control. However, the results obtained from single-
classification ANOVA indicated that no significant change of hemoglobin concentration 
in the chamber. The significant change showed in the pair t-test might come from the 
change in the bench blood sample itself. Together, these data demonstrated that the flow 
chamber itself and the flow environment in the device did not induce hemolysis.   
 Non-physiological blood flow can trigger platelet activation. Activated platelets 
will change in shape and start to adhere to other platelets and form a clot. In addition, 
activated platelets can lead to thrombosis and contribute to the development of 
atherosclerosis. (Bluestein et al., 2004; Davi and Patrono, 2007). In our experiments, 
platelet activation was measured by CD62P expression, using flow cytometry. Under 
static conditions, an increased CD62P expression (n=6, P < 0.05) was observed on 
platelets that were placed in the flow chamber after 3 hours of incubation. However, no 
change was observed on these platelets during the first two hours when incubated in the 
flow chamber. This result was not expected. It might come from the slow self-activation 
of platelets when a large amount of platelets (100,000/µl at 250 ml) were kept stagnant 
together. The results from dynamic experiments indicated that with the presence of the 
St. Jude bileaflet mechanical heart valves, the flow conditions in the testing fluid 
chamber did not induce any platelet activation (n=6) after 90 minutes of circulation, 
which was corresponding to 8400 valve passages. These data demonstrated that the 
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materials and the flow dynamics of the flow chamber were suitable for circulating 
platelets. In summary, the flow chamber, especially under dynamic flow conditions, can 
provide a physiologically relevant environment to study heart valve functions, without 
damaging circulating red blood cells and platelets.  
5.3 Numerical simulation 
 Numerical simulations were conducted to evaluate the flow patterns in the flow 
chamber. Computational fluid dynamics (CFD) is an effective tool to estimate the flow 
patterns when direct measurement was not available, provided the usage of closely 
matched geometry of the model and boundary conditions. In this study, the flow patterns 
inside the chamber at various instances during systole and diastole were analyzed. To 
simplify the modeling process, the performance of the testing fluid chamber was modeled 
under 4 different conditions, depending on the volume of fluid ejected out of the outlet 
valve: 20 ml, 40 ml, 60 ml, and 80 ml. In addition, valve geometry replicating the St. 
Jude bileaflet mechanical heart valve was designed and included in the analysis. For 
simplification, the valve configuration was such that one of them was fully open while 
the other was closed, chosen based on systole or diastole. In other words, the valve in the 
flow direction was always open, while the other was always closed. Physiologically, it 
takes 20 to 30 msec for the aortic valve to open or close (Krisnan B.Chandran et al., 
2007b). When fully open or closed, the valve will stay in that status (open or closed) for 
approximately 230 to 500 msec. Since the opening or closing time is minimum compared 
to the time when the valve stays open or closed, the assumption to keep them at the open 
or closed location was suitable, especially when the ejection and injection took about 270 
msec and 430 msec respectively (Frederic H.Martini and Judi L.Nath, 2009).  
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 The model was meshed using an unstructured mesh, in order to optimize the 
computational time, and the spatial and temporal resolution of the results. A laminar 
solver was used to simulate fluid flow in this model, to check the mesh integrity, 
geometry, and the boundary conditions. The results from these simulations revealed a 
proper laminar flow patterns in both systolic (fluid from chamber through the valves) and 
diastolic (fluid flow from the channel through the valves) configurations. The maximum 
velocity estimated by the laminar solver (end of systole and diastole) in systolic 
configuration was 0.5086 m/s, while that in diastolic configuration was 0.4209 m/s. In 
both the configurations, the maximum velocity was found near the open valve. 
Estimation from turbulent solver showed the similar results - the maximum velocity was 
0.5106 m/s in systolic configuration (end of systole and diastole), and 0.4321 m/s in 
diastole. Later, flow in the chamber was solved using k-ω solver in order to check for the 
existence of turbulence. The results revealed that the maximum Reynolds number was 
2127.69 during systole. By comparing the flow fields, estimated by both laminar and 
turbulent models (Figure 4.11 and Figure 4.15), no turbulence was detected in both 
systolic and diastolic configurations. Also, similar maximum velocities were estimated by 
laminar and turbulent models (systolic: laminar-0.5086 m/s, turbulent-0.5106 m/s; 
diastolic: laminar-0.4209 m/s, turbulent-0.4321 m/s).  
 Combined, results obtained from the in vitro experiment and numerical 
simulations demonstrated that the structure of the testing fluid chamber did not induce 
complex flow conditions and the flow environment generated by the chamber was 
suitable for heart valve dynamic performance studies. 
CHAPTER VI 
 
 
CONCLUSIONS 
A biocompatible flow chamber similar to left ventricular assist device was built to 
study the hemodynamic performance of prosthetic heart valves (PHVs). A detailed design 
of the flow chamber components was modeled using the computer aided design software 
(Pro-E Wildfire 4.0 PTC). The geometrical parameters of the major components (testing 
fluid chamber, water chamber, and transparent valve socket) were designed based on 
physiological conditions. The transparent part (transparent valve socket) of the flow 
chamber provided a direct visualization of the valve movement. The materials chosen 
were biocompatible and have been previously used in many medical devices. All 
together, the flow chamber provided a more economic and flexible experimental setup to 
study the performance of PHVs. 
 Biocompatibility of the flow chamber towards platelets and red blood cells were 
conducted under static and dynamic conditions. The static condition was conducted to 
check the surface contact induced platelet and red blood cell response, while dynamic 
condition, with St. Jude bileaflet mechanical heart valves, was to check the flow induced 
response. The results indicated that the flow chamber did not induce platelet activation 
and hemolysis under static or dynamic conditions. A computational fluid dynamic 
analysis of flow inside the chamber was conducted using ANSYS CFX-12.0. 
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Both systolic and diastolic conditions were simulated using laminar and turbulent 
solver (with ejection and injection volume of 20 ml, 40 ml, 60 ml, and 80 ml). A detailed 
velocity vectors distribution inside the flow chamber, and Reynolds number of each 
condition was reported. The results revealed that no turbulence was present in the flow 
chamber. Overall, the design of the flow chamber meets the materials and fluid dynamics 
requirements to conduct PHV study. 
 In the future, various novel designs of PHVs can be evaluated in the flow 
chamber that was built in this study. The performance of PHVs can be accessed through 
their effect on hemolysis and platelet activation under dynamic conditions. In addition, 
biocompatibility of PHV’s made out of new material can be accessed under dynamic 
conditions. Techniques like Laser Doppler Velocimetry can be incorporated to the flow 
chamber to observe the platelet trajectory and to calculate other flow variables. The other 
recommendation is to involve a fluid solid interaction solver to improve the 
computational fluid dynamics simulation of flow conditions inside the chamber. 
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APPPENDIX A 
 
CFX COMMAND LANGUAGE (CCL) 
LAMINAR FLOW MODEL (80ml, DIASTOLE) 
 
# State file created:  2010/11/21 02:57:58 
# CFX-12.0.1 build 2009.04.14-23.02 
 
LIBRARY: 
  MATERIAL: Water 
    Material Description = Water (liquid) 
    Material Group = Water Data, Constant Property Liquids 
    Option = Pure Substance 
    Thermodynamic State = Liquid 
    PROPERTIES: 
      Option = General Material 
      EQUATION OF STATE: 
        Density = 997.0 [kg m^-3] 
        Molar Mass = 18.02 [kg kmol^-1] 
        Option = Value 
      END 
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SPECIFIC HEAT CAPACITY: 
        Option = Value 
        Specific Heat Capacity = 4181.7 [J kg^-1 K^-1] 
        Specific Heat Type = Constant Pressure 
      END 
      REFERENCE STATE: 
        Option = Specified Point 
        Reference Pressure = 1 [atm] 
        Reference Specific Enthalpy = 0.0 [J/kg] 
        Reference Specific Entropy = 0.0 [J/kg/K] 
        Reference Temperature = 25 [C] 
      END 
      DYNAMIC VISCOSITY: 
        Dynamic Viscosity = 8.899E-4 [kg m^-1 s^-1] 
        Option = Value 
      END 
      THERMAL CONDUCTIVITY: 
        Option = Value 
        Thermal Conductivity = 0.6069 [W m^-1 K^-1] 
      END 
      ABSORPTION COEFFICIENT: 
        Absorption Coefficient = 1.0 [m^-1] 
        Option = Value 
      END 
      SCATTERING COEFFICIENT: 
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        Option = Value 
        Scattering Coefficient = 0.0 [m^-1] 
      END 
      REFRACTIVE INDEX: 
        Option = Value 
        Refractive Index = 1.0 [m m^-1] 
      END 
      THERMAL EXPANSIVITY: 
        Option = Value 
        Thermal Expansivity = 2.57E-04 [K^-1] 
      END 
    END 
  END 
END 
FLOW: Flow Analysis 1 
  SOLUTION UNITS: 
    Angle Units = [rad] 
    Length Units = [m] 
    Mass Units = [kg] 
    Solid Angle Units = [sr] 
    Temperature Units = [K] 
    Time Units = [s] 
  END 
  ANALYSIS TYPE: 
    Option = Steady State 
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    EXTERNAL SOLVER COUPLING: 
      Option = None 
    END 
  END 
  DOMAIN: Default Domain Modified 
    Coord Frame = Coord 0 
    Domain Type = Fluid 
    Location = BODY_HOUSING,BODY_OUTLET_WALL 
    BOUNDARY: Default Fluid Fluid Interface in Default Domain Modified Side 1 
      Boundary Type = INTERFACE 
      Location = HOUSING_OUTLET_1 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = Conservative Interface Flux 
        END 
      END 
    END 
    BOUNDARY: outlet 
      Boundary Type = WALL 
      Location = OUTLET 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
      END 
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    END 
    BOUNDARY: valve close 
      Boundary Type = WALL 
      Location = VALVE_INLET 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
      END 
    END 
    BOUNDARY: wall 
      Boundary Type = WALL 
      Location = DIAPHRAGM,HOUSING,INLETWALL 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
      END 
    END 
    DOMAIN MODELS: 
      BUOYANCY MODEL: 
        Option = Non Buoyant 
      END 
      DOMAIN MOTION: 
        Option = Stationary 
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      END 
      MESH DEFORMATION: 
        Option = None 
      END 
      REFERENCE PRESSURE: 
        Reference Pressure = 80 [mm Hg] 
      END 
    END 
    FLUID DEFINITION: Fluid 1 
      Material = Water 
      Option = Material Library 
      MORPHOLOGY: 
        Option = Continuous Fluid 
      END 
    END 
    FLUID MODELS: 
      COMBUSTION MODEL: 
        Option = None 
      END 
      HEAT TRANSFER MODEL: 
        Option = None 
      END 
      THERMAL RADIATION MODEL: 
        Option = None 
      END 
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      TURBULENCE MODEL: 
        Option = Laminar 
      END 
    END 
  END 
  DOMAIN: cylin 
    Coord Frame = Coord 0 
    Domain Type = Fluid 
    Location = BODY_CYLINDER_INLET 
    BOUNDARY: Default Fluid Fluid Interface in cylin Side 1 
      Boundary Type = INTERFACE 
      Location = CONNECTION_INLET_1 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = Conservative Interface Flux 
        END 
      END 
    END 
    BOUNDARY: inlet 
      Boundary Type = INLET 
      Location = INLET 
      BOUNDARY CONDITIONS: 
        FLOW REGIME: 
          Option = Subsonic 
        END 
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        MASS AND MOMENTUM: 
          Normal Speed = 18.9458 [cm s^-1] 
          Option = Normal Speed 
        END 
      END 
    END 
    BOUNDARY: wall cylin 
      Boundary Type = WALL 
      Location = CYLINDER_INLET 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
      END 
    END 
    DOMAIN MODELS: 
      BUOYANCY MODEL: 
        Option = Non Buoyant 
      END 
      DOMAIN MOTION: 
        Option = Stationary 
      END 
      MESH DEFORMATION: 
        Option = None 
      END 
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      REFERENCE PRESSURE: 
        Reference Pressure = 80 [mm Hg] 
      END 
    END 
    FLUID DEFINITION: Fluid 1 
      Material = Water 
      Option = Material Library 
      MORPHOLOGY: 
        Option = Continuous Fluid 
      END 
    END 
    FLUID MODELS: 
      COMBUSTION MODEL: 
        Option = None 
      END 
      HEAT TRANSFER MODEL: 
        Option = None 
      END 
      THERMAL RADIATION MODEL: 
        Option = None 
      END 
      TURBULENCE MODEL: 
        Option = Laminar 
      END 
    END 
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  END 
  DOMAIN: tube 
    Coord Frame = Coord 0 
    Domain Type = Fluid 
    Location = BODY_INLET_WALL 
    BOUNDARY: Default Fluid Fluid Interface in tube Side 2 
      Boundary Type = INTERFACE 
      Location = CONNECTION_INLET_2,HOUSING_OUTLET_2 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = Conservative Interface Flux 
        END 
      END 
    END 
    BOUNDARY: valve open 
      Boundary Type = WALL 
      Location = VALVE_OUTLET 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
      END 
    END 
    BOUNDARY: wall tube 
      Boundary Type = WALL 
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      Location = OUTLETWALL 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
      END 
    END 
    DOMAIN MODELS: 
      BUOYANCY MODEL: 
        Option = Non Buoyant 
      END 
      DOMAIN MOTION: 
        Option = Stationary 
      END 
      MESH DEFORMATION: 
        Option = None 
      END 
      REFERENCE PRESSURE: 
        Reference Pressure = 80 [mm Hg] 
      END 
    END 
    FLUID DEFINITION: Fluid 1 
      Material = Water 
      Option = Material Library 
      MORPHOLOGY: 
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        Option = Continuous Fluid 
      END 
    END 
    FLUID MODELS: 
      COMBUSTION MODEL: 
        Option = None 
      END 
      HEAT TRANSFER MODEL: 
        Option = None 
      END 
      THERMAL RADIATION MODEL: 
        Option = None 
      END 
      TURBULENCE MODEL: 
        Option = Laminar 
      END 
    END 
  END 
  DOMAIN INTERFACE: Default Fluid Fluid Interface 
    Boundary List1 = Default Fluid Fluid Interface in Default Domain Modified \ 
      Side 1,Default Fluid Fluid Interface in cylin Side 1 
    Boundary List2 = Default Fluid Fluid Interface in tube Side 2 
    Interface Type = Fluid Fluid 
    INTERFACE MODELS: 
      Option = General Connection 
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      FRAME CHANGE: 
        Option = None 
      END 
      MASS AND MOMENTUM: 
        Option = Conservative Interface Flux 
        MOMENTUM INTERFACE MODEL: 
          Option = None 
        END 
      END 
      PITCH CHANGE: 
        Option = None 
      END 
    END 
    MESH CONNECTION: 
      Option = GGI 
    END 
  END 
  INITIALISATION: 
    Option = Automatic 
    INITIAL CONDITIONS: 
      Velocity Type = Cartesian 
      CARTESIAN VELOCITY COMPONENTS: 
        Option = Automatic 
      END 
      STATIC PRESSURE: 
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        Option = Automatic 
      END 
    END 
  END 
  OUTPUT CONTROL: 
    RESULTS: 
      File Compression Level = Default 
      Option = Standard 
    END 
  END 
  SOLVER CONTROL: 
    ADVECTION SCHEME: 
      Option = High Resolution 
    END 
    CONVERGENCE CONTROL: 
      Length Scale Option = Conservative 
      Maximum Number of Iterations = 250 
      Minimum Number of Iterations = 1 
      Timescale Control = Auto Timescale 
      Timescale Factor = 1.0 
    END 
    CONVERGENCE CRITERIA: 
      Residual Target = 1.E-4 
      Residual Type = RMS 
    END 
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    DYNAMIC MODEL CONTROL: 
      Global Dynamic Model Control = On 
    END 
  END 
END 
COMMAND FILE: 
  Version = 12.0.1 
END 
 
TURBULENT FLOW MODEL (80 ml, DIASTOLE) 
 
# State file created:  2010/11/21 02:56:19 
# CFX-12.0.1 build 2009.04.14-23.02 
 
LIBRARY: 
  MATERIAL: Water 
    Material Description = Water (liquid) 
    Material Group = Water Data, Constant Property Liquids 
    Option = Pure Substance 
    Thermodynamic State = Liquid 
    PROPERTIES: 
      Option = General Material 
      EQUATION OF STATE: 
        Density = 997.0 [kg m^-3] 
        Molar Mass = 18.02 [kg kmol^-1] 
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        Option = Value 
      END 
      SPECIFIC HEAT CAPACITY: 
        Option = Value 
        Specific Heat Capacity = 4181.7 [J kg^-1 K^-1] 
        Specific Heat Type = Constant Pressure 
      END 
      REFERENCE STATE: 
        Option = Specified Point 
        Reference Pressure = 1 [atm] 
        Reference Specific Enthalpy = 0.0 [J/kg] 
        Reference Specific Entropy = 0.0 [J/kg/K] 
        Reference Temperature = 25 [C] 
      END 
      DYNAMIC VISCOSITY: 
        Dynamic Viscosity = 8.899E-4 [kg m^-1 s^-1] 
        Option = Value 
      END 
      THERMAL CONDUCTIVITY: 
        Option = Value 
        Thermal Conductivity = 0.6069 [W m^-1 K^-1] 
      END 
      ABSORPTION COEFFICIENT: 
        Absorption Coefficient = 1.0 [m^-1] 
        Option = Value 
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      END 
      SCATTERING COEFFICIENT: 
        Option = Value 
        Scattering Coefficient = 0.0 [m^-1] 
      END 
      REFRACTIVE INDEX: 
        Option = Value 
        Refractive Index = 1.0 [m m^-1] 
      END 
      THERMAL EXPANSIVITY: 
        Option = Value 
        Thermal Expansivity = 2.57E-04 [K^-1] 
      END 
    END 
  END 
END 
FLOW: Flow Analysis 1 
  SOLUTION UNITS: 
    Angle Units = [rad] 
    Length Units = [m] 
    Mass Units = [kg] 
    Solid Angle Units = [sr] 
    Temperature Units = [K] 
    Time Units = [s] 
  END 
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  ANALYSIS TYPE: 
    Option = Steady State 
    EXTERNAL SOLVER COUPLING: 
      Option = None 
    END 
  END 
  DOMAIN: Default Domain Modified 
    Coord Frame = Coord 0 
    Domain Type = Fluid 
    Location = BODY_HOUSING,BODY_OUTLET_WALL 
    BOUNDARY: Default Fluid Fluid Interface in Default Domain Modified Side 1 
      Boundary Type = INTERFACE 
      Location = HOUSING_OUTLET_1 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = Conservative Interface Flux 
        END 
        TURBULENCE: 
          Option = Conservative Interface Flux 
        END 
      END 
    END 
    BOUNDARY: outlet 
      Boundary Type = WALL 
      Location = OUTLET 
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      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
        WALL ROUGHNESS: 
          Option = Smooth Wall 
        END 
      END 
    END 
    BOUNDARY: valve close 
      Boundary Type = WALL 
      Location = VALVE_INLET 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
        WALL ROUGHNESS: 
          Option = Smooth Wall 
        END 
      END 
    END 
    BOUNDARY: wall 
      Boundary Type = WALL 
      Location = DIAPHRAGM,HOUSING,INLETWALL 
      BOUNDARY CONDITIONS: 
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        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
        WALL ROUGHNESS: 
          Option = Smooth Wall 
        END 
      END 
    END 
    DOMAIN MODELS: 
      BUOYANCY MODEL: 
        Option = Non Buoyant 
      END 
      DOMAIN MOTION: 
        Option = Stationary 
      END 
      MESH DEFORMATION: 
        Option = None 
      END 
      REFERENCE PRESSURE: 
        Reference Pressure = 80 [mm Hg] 
      END 
    END 
    FLUID DEFINITION: Fluid 1 
      Material = Water 
      Option = Material Library 
104 
 
      MORPHOLOGY: 
        Option = Continuous Fluid 
      END 
    END 
    FLUID MODELS: 
      COMBUSTION MODEL: 
        Option = None 
      END 
      HEAT TRANSFER MODEL: 
        Option = None 
      END 
      THERMAL RADIATION MODEL: 
        Option = None 
      END 
      TURBULENCE MODEL: 
        Option = k omega 
      END 
      TURBULENT WALL FUNCTIONS: 
        Option = Automatic 
      END 
    END 
  END 
  DOMAIN: cylin 
    Coord Frame = Coord 0 
    Domain Type = Fluid 
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    Location = BODY_CYLINDER_INLET 
    BOUNDARY: Default Fluid Fluid Interface in cylin Side 1 
      Boundary Type = INTERFACE 
      Location = CONNECTION_INLET_1 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = Conservative Interface Flux 
        END 
        TURBULENCE: 
          Option = Conservative Interface Flux 
        END 
      END 
    END 
    BOUNDARY: inlet 
      Boundary Type = INLET 
      Location = INLET 
      BOUNDARY CONDITIONS: 
        FLOW REGIME: 
          Option = Subsonic 
        END 
        MASS AND MOMENTUM: 
          Normal Speed = 18.9458 [cm s^-1] 
          Option = Normal Speed 
        END 
        TURBULENCE: 
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          Option = Medium Intensity and Eddy Viscosity Ratio 
        END 
      END 
    END 
    BOUNDARY: wall cylin 
      Boundary Type = WALL 
      Location = CYLINDER_INLET 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
        WALL ROUGHNESS: 
          Option = Smooth Wall 
        END 
      END 
    END 
    DOMAIN MODELS: 
      BUOYANCY MODEL: 
        Option = Non Buoyant 
      END 
      DOMAIN MOTION: 
        Option = Stationary 
      END 
      MESH DEFORMATION: 
        Option = None 
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      END 
      REFERENCE PRESSURE: 
        Reference Pressure = 80 [mm Hg] 
      END 
    END 
    FLUID DEFINITION: Fluid 1 
      Material = Water 
      Option = Material Library 
      MORPHOLOGY: 
        Option = Continuous Fluid 
      END 
    END 
    FLUID MODELS: 
      COMBUSTION MODEL: 
        Option = None 
      END 
      HEAT TRANSFER MODEL: 
        Option = None 
      END 
      THERMAL RADIATION MODEL: 
        Option = None 
      END 
      TURBULENCE MODEL: 
        Option = k omega 
      END 
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      TURBULENT WALL FUNCTIONS: 
        Option = Automatic 
      END 
    END 
  END 
  DOMAIN: tube 
    Coord Frame = Coord 0 
    Domain Type = Fluid 
    Location = BODY_INLET_WALL 
    BOUNDARY: Default Fluid Fluid Interface in tube Side 2 
      Boundary Type = INTERFACE 
      Location = CONNECTION_INLET_2,HOUSING_OUTLET_2 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = Conservative Interface Flux 
        END 
        TURBULENCE: 
          Option = Conservative Interface Flux 
        END 
      END 
    END 
    BOUNDARY: valve open 
      Boundary Type = WALL 
      Location = VALVE_OUTLET 
      BOUNDARY CONDITIONS: 
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        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
        WALL ROUGHNESS: 
          Option = Smooth Wall 
        END 
      END 
    END 
    BOUNDARY: wall tube 
      Boundary Type = WALL 
      Location = OUTLETWALL 
      BOUNDARY CONDITIONS: 
        MASS AND MOMENTUM: 
          Option = No Slip Wall 
        END 
        WALL ROUGHNESS: 
          Option = Smooth Wall 
        END 
      END 
    END 
    DOMAIN MODELS: 
      BUOYANCY MODEL: 
        Option = Non Buoyant 
      END 
      DOMAIN MOTION: 
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        Option = Stationary 
      END 
      MESH DEFORMATION: 
        Option = None 
      END 
      REFERENCE PRESSURE: 
        Reference Pressure = 80 [mm Hg] 
      END 
    END 
    FLUID DEFINITION: Fluid 1 
      Material = Water 
      Option = Material Library 
      MORPHOLOGY: 
        Option = Continuous Fluid 
      END 
    END 
    FLUID MODELS: 
      COMBUSTION MODEL: 
        Option = None 
      END 
      HEAT TRANSFER MODEL: 
        Option = None 
      END 
      THERMAL RADIATION MODEL: 
        Option = None 
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      END 
      TURBULENCE MODEL: 
        Option = k omega 
      END 
      TURBULENT WALL FUNCTIONS: 
        Option = Automatic 
      END 
    END 
  END 
  DOMAIN INTERFACE: Default Fluid Fluid Interface 
    Boundary List1 = Default Fluid Fluid Interface in Default Domain Modified \ 
      Side 1,Default Fluid Fluid Interface in cylin Side 1 
    Boundary List2 = Default Fluid Fluid Interface in tube Side 2 
    Interface Type = Fluid Fluid 
    INTERFACE MODELS: 
      Option = General Connection 
      FRAME CHANGE: 
        Option = None 
      END 
      MASS AND MOMENTUM: 
        Option = Conservative Interface Flux 
        MOMENTUM INTERFACE MODEL: 
          Option = None 
        END 
      END 
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      PITCH CHANGE: 
        Option = None 
      END 
    END 
    MESH CONNECTION: 
      Option = GGI 
    END 
  END 
  INITIALISATION: 
    Option = Automatic 
    INITIAL CONDITIONS: 
      Velocity Type = Cartesian 
      CARTESIAN VELOCITY COMPONENTS: 
        Option = Automatic 
      END 
      STATIC PRESSURE: 
        Option = Automatic 
      END 
      TURBULENCE INITIAL CONDITIONS: 
        Option = Medium Intensity and Eddy Viscosity Ratio 
      END 
    END 
  END 
  OUTPUT CONTROL: 
    RESULTS: 
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      File Compression Level = Default 
      Option = Standard 
    END 
  END 
  SOLVER CONTROL: 
    Turbulence Numerics = First Order 
    ADVECTION SCHEME: 
      Option = High Resolution 
    END 
    CONVERGENCE CONTROL: 
      Length Scale Option = Conservative 
      Maximum Number of Iterations = 250 
      Minimum Number of Iterations = 1 
      Timescale Control = Auto Timescale 
      Timescale Factor = 1.0 
    END 
    CONVERGENCE CRITERIA: 
      Residual Target = 1.E-4 
      Residual Type = RMS 
    END 
    DYNAMIC MODEL CONTROL: 
      Global Dynamic Model Control = On 
    END 
  END 
END 
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COMMAND FILE: 
  Version = 12.0.1 
END 
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APPENDIX B 
CONFERENCE ABSTRACTS 
Experimental Biology Conference, Anaheim, CA, April 2010 
A flow chamber to study the performance of artificial heart valves 
Abstract number: 1065.3 
Wei Yin, Ek Ching Ngwe, David A. Rubenstein 
School of Mechanical and Aerospace Engineering, Oklahoma State University 
The goal of this study was to build a flow chamber to study the hemodynamic 
performance of a novel artificial heart valve made of cross-linked aerogels. This low 
density new material has a significantly improved mechanical strength and a promising 
biocompatibility with the cardiovascular system. The housing of the flow chamber was 
made of Teflon and clear PVC. Two aerogel heart valves were fixed oppositely in the 
chamber, controlling flow direction. Through a polyurethane diaphragm, flow was driven 
by a reciprocating pump through water. The flow rate of the chamber was fixed at 5L/min 
with a stroke volume of 80 ml and stroke rate of 72 min-1. The systolic/diastolic ratio was 
0.375. The performance of the system was examined using whole blood, platelet rich 
plasma (PRP) and washed platelets, under static and dynamic conditions. Hemolysis was 
measured with whole blood using a spectrophotometer. Platelet activation was measured 
by platelet surface P-selectin expression after PRP contact with the system. Platelet 
thrombogenecity was examined using a prothrombinase assay after washed platelets were 
placed into the chamber. Preliminary results indicate that the flow chamber does not 
induce hemolysis or platelet activation under static conditions, while its dynamic 
performance depends on the valves used. These results indicate it's feasible to use the 
flow chamber to study the hemodynamic performance of artificial heart valves.  
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Oklahoma Research Day, Lawton, OK, November, 2010 
A Biocompatible Flow Device to Study the Hemodynamic Performance of Prosthetic 
Heart Valves 
 
Ek Ching Ngwe, David A. Rubenstein, Wei Yin 
School of Mechanical and Aerospace Engineering, Oklahoma State University 
Heart valve diseases claim more than 250,000 victims each year in the United State and 
one treatment is to replace it with a prosthetic heart valve. The goal of this study was to 
build a biocompatible flow device (following the design of a left ventricular assist 
device) to study the hemodynamic performance of prosthetic heart valves. The flow 
device consists of two fluid chambers which made of Teflon and clear PVC, separated by 
a flexible latex diaphragm. One chamber was connected to a reciprocating pump which 
drives the diaphragm move and causes fluid in the other chamber to circulate through two 
heart valves. The biocompatibility of this flow device towards blood platelets and red 
blood cells were tested under static and dynamic conditions. For static testing, washed 
platelets and whole blood were placed in the test chamber for up to 6 hours. Platelet 
surface P-selectin expression and hemolysis were examined every hour using flow 
cytometry and spectrophotometer (at 540nm).For dynamic testing, two St. Jude bileaflet 
mechanical heart valves were placed into the test chamber to control the flow direction. 
Washed platelets and whole blood were circulated in the chamber for 90 minutes and 
examined every 15 minutes. The results demonstrated that the flow device did not induce 
hemolysis or platelet activation. In parallel, a 3D computational fluid dynamics model 
was built to study flow conditions and the results indicated that the flow device did not 
induce turbulence (maximum Reynolds number was ~2100), which is desirable to study 
cellular functions. These results demonstrated the feasibility of using this flow device to 
study the hemodynamic performance of prosthetic heart valves. 
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Heart valve diseases claim more than 250,000 victims each year in the United 
States. One option to treat a diseased heart valve is to replace it with a prosthetic heart 
valve. There are two main types of prosthetic heart valves, mechanical heart valves and 
bioprosthetic heart valves. The goal of this study was to build a biocompatible flow 
chamber (following the design of a left ventricular assist device) to study the 
hemodynamic performance of prosthetic heart valves. The flow chamber consists of two 
fluid chambers separated by a flexible latex diaphragm. One chamber is filled with water 
(water chamber) and connected to a Harvard reciprocating pump, which drives the 
diaphragm to move up and down and causes fluid in the other chamber (testing fluid 
chamber) to circulate through two heart valves. The biocompatibility of this flow 
chamber towards blood platelets and red blood cells were tested under static and dynamic 
conditions. For static testing, washed platelets were placed in the testing fluid chamber 
for up to 5 hours. Samples were taken out every hour and platelet surface P-selectin 
expression was measured using flow cytometry. To investigate the effect of the chamber 
on red blood cells, whole blood was placed in the test chamber for up to 6 hours. 
Hemolysis was measured every hour (at 540 nm). For dynamic testing, two St. Jude 
bileaflet mechanical heart valves were placed into the testing fluid chamber to control the 
flow direction. The flow rate of the system was fixed at 5 L/min with a stroke volume of 
80mL and stroke rate of 72 min-1. The systolic /diastolic ratio was 0.375. Washed 
platelets were circulated in the chamber for 90 minutes and platelet surface P-selectin 
expression was examined every 15 minutes. For hemolysis measurement, whole blood 
was circulated through the two heart valves for 90 minutes and blood samples were taken 
every 15 minutes. The results demonstrated that the flow chamber did not induce 
hemolysis and platelet activation under static or dynamic conditions, with or without the 
St. Jude bileaflet mechanical heart valves. In parallel, a 3D computational fluid dynamics 
model was built to study the flow conditions in the flow chamber. The results indicated 
that the design of the flow chamber did not induce any turbulence in the testing fluid 
chamber (maximum Reynolds number was ~2100), which is desirable to study cellular 
functions. These results demonstrated the feasibility of using this flow chamber to study 
the hemodynamic performance of prosthetic heart valves. 
